Canid, the end-to-end platform for vaccine automation and management, announced that it has closed $1.5 million in new funding to expand its geographic footprint to 10 new states across the U.S. and add new tools to manage vaccine patient populations. This round was led by SeedtoB Capital, an early-stage fund focused on healthcare innovation and artificial intelligence, with participation from FJ Labs, Alumni Ventures, I2BF and MKT1.